Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

1.

Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.

Schulz S, Sinn P, Golatta M, Rauch G, Junkermann H, Schuetz F, Sohn C, Heil J.

Breast. 2013 Aug;22(4):537-42. doi: 10.1016/j.breast.2012.11.002. Epub 2012 Dec 11.

PMID:
23237921
[PubMed - indexed for MEDLINE]
2.

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.

Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM.

J Am Coll Surg. 2005 Apr;200(4):516-26.

PMID:
15804465
[PubMed - indexed for MEDLINE]
3.

Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.

Park HS, Park S, Cho J, Park JM, Kim SI, Park BW.

J Surg Oncol. 2013 Mar;107(4):388-92. doi: 10.1002/jso.23273. Epub 2012 Sep 24.

PMID:
23007901
[PubMed - indexed for MEDLINE]
4.

Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.

Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE.

Breast Cancer Res Treat. 2006 Aug;98(3):311-4. Epub 2006 Mar 22.

PMID:
16552627
[PubMed - indexed for MEDLINE]
5.

Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.

Tan JC, McCready DR, Easson AM, Leong WL.

Ann Surg Oncol. 2007 Feb;14(2):638-45. Epub 2006 Nov 14.

PMID:
17103256
[PubMed - indexed for MEDLINE]
6.
7.

Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.

Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD.

Curr Surg. 2005 Mar-Apr;62(2):253-7.

PMID:
15796952
[PubMed - indexed for MEDLINE]
8.

[Predictive factors of invasion with initial diagnosis of ductal carcinoma in situ based on core biopsy].

Kósa C, Garami Z, Dinya T, Fülöp B.

Magy Seb. 2012 Aug;65(4):218-21. doi: 10.1556/MaSeb.65.2012.4.8. Hungarian.

PMID:
22940391
[PubMed - indexed for MEDLINE]
9.

Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.

Han JS, Molberg KH, Sarode V.

Breast J. 2011 May-Jun;17(3):223-9. doi: 10.1111/j.1524-4741.2011.01069.x. Epub 2011 Mar 24.

PMID:
21545433
[PubMed - indexed for MEDLINE]
10.

Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?

McLaughlin SA, Stempel M, Morris EA, Liberman L, King TA.

Cancer. 2008 Mar 15;112(6):1214-21. doi: 10.1002/cncr.23298.

PMID:
18257089
[PubMed - indexed for MEDLINE]
Free Article
11.

Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.

Kim J, Han W, Lee JW, You JM, Shin HC, Ahn SK, Moon HG, Cho N, Moon WK, Park IA, Noh DY.

Breast. 2012 Oct;21(5):641-5. doi: 10.1016/j.breast.2012.06.012. Epub 2012 Jun 30.

PMID:
22749854
[PubMed - indexed for MEDLINE]
12.

Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients.

Moran CJ, Kell MR, Flanagan FL, Kennedy M, Gorey TF, Kerin MJ.

Am J Surg. 2007 Aug;194(2):172-5.

PMID:
17618799
[PubMed - indexed for MEDLINE]
13.

Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.

Tunon-de-Lara C, Giard S, Buttarelli M, Blanchot J, Classe JM, Baron M, Monnier B, Houvenaeghel G.

Breast J. 2008 Mar-Apr;14(2):135-40. doi: 10.1111/j.1524-4741.2007.00543.x.

PMID:
18315691
[PubMed - indexed for MEDLINE]
14.

Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.

Kuwajerwala NK, Dekhne NS, Pentiak PA, Fend D, Callahan RE, Amine M, Lucia V, Swartz J.

Clin Breast Cancer. 2013 Aug;13(4):287-91. doi: 10.1016/j.clbc.2013.02.006. Epub 2013 May 23.

PMID:
23706482
[PubMed - indexed for MEDLINE]
15.

The use of sentinel lymph node biopsy in ductal carcinoma in situ.

Schneider C, Trocha S, McKinley B, Shaw J, Bielby S, Blackhurst D, Jones Y, Cornett W.

Am Surg. 2010 Sep;76(9):943-6.

PMID:
20836339
[PubMed - indexed for MEDLINE]
16.

Sentinel lymph node biopsy in selected cases of ductal carcinoma in situ.

Collado MV, Ruiz-Tovar J, García-Villanueva A, Rojo R, Latorre L, Rioja ME, González-Palacios F.

Clin Transl Oncol. 2010 Jul;12(7):499-502. doi: 10.1007/s12094-010-0543-3.

PMID:
20615827
[PubMed - indexed for MEDLINE]
17.

Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?

Murthy V, Chamberlain RS.

Clin Breast Cancer. 2013 Jun;13(3):180-7. doi: 10.1016/j.clbc.2012.12.001. Epub 2013 Jan 26.

PMID:
23357305
[PubMed - indexed for MEDLINE]
19.

Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.

Meijnen P, Oldenburg HS, Loo CE, Nieweg OE, Peterse JL, Rutgers EJ.

Br J Surg. 2007 Aug;94(8):952-6.

PMID:
17440955
[PubMed - indexed for MEDLINE]
20.

[Ductal carcinoma in situ (DCIS) and biopsy of the sentinel lymph node].

Chvalný P, Donát R, Dyttert D, Siska D, Sabol M, Králik R, Mracna P, Malina J, Veselý J, Duchaj B, Cích D, Lehotská V, Rauová K, Smreková M, Galbavý S, Macák D, Macháleková K, Bokes T.

Rozhl Chir. 2011 Jun;90(6):352-60. Czech.

PMID:
22026103
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk